About three thousand Americans suffer from mesothelioma each year. A rare cancer, mesothelioma is characterized by a long latency period and a short life expectancy. It can take decades for mesothelioma to demonstrate symptoms in patients, but following diagnosis average patient life expectancy is eighteen months.
There are mesothelioma treatments available, which directly fight the cancer. These include surgery, radiation therapy and chemotherapy. Many patients are also turning to palliative care to manage the pain and quality of life for the time they have left.
Following a diagnosis of mesothelioma at age 54, one man is facing the realities of his case with unexpected selflessness. Richard Mosca decided that his time would be spent advocating for others suffering from mesothelioma and similar illnesses. The Mesothelioma Applied Research Foundation nominated Mosca to evaluate potential research projects.
Now, Mosca works with other patients, survivors and family members of those affected by military related illnesses and injuries on the Peer Reviewed Medical Research Program (PRMRP). The PRMRP is made possible through Congressionally Directed Medical Research Programs of the Department of Defense (DoD). The DoD’s vision to
View the Original article